SCHD (Schwab U.S. Dividend Equity ETF): 5 Keys, Monday Predicted Opening Price & Price Call? 🔥
1 extracted signal · 0 resolved · 1 still active
StockInvest.usIndependent analyst profile- Source published
- 30 Oct 2026, 23:21 UTC
- Recorded by Tahlil Plus
- 31 Oct 2026, 00:38 UTC
AI-generated source summary
The SCHD ETF is exhibiting positive short-term signals, having broken its horizontal trendline upwards. This suggests an accelerating upward momentum. Technical indicators like the 3-month MACD and the relationship between short-term and long-term moving averages support a bullish outlook. A buy signal was generated from a pivot bottom on September 30, 2026, and the price has since risen 9.99%. Further upside is indicated by a new top pivot. Volume is also rising in conjunction with price, reinforcing the bullish technical signal. Key support levels are identified at $35.37 and $33.86. A break below these levels would invalidate the bullish short-term outlook and could trigger sell signals. The risk is assessed as medium due to daily movements and an RSI14 of 86, which is nearing overbought territory. The price of $35.78 is currently considered undervalued, with potential for upward movement towards $36.10. A stop-loss is suggested at $34.03 to manage risk.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.